Mainstream

Keros Ends Mid Stage Trial For Lead Asset After Adverse Events

Keros ends mid-stage trial for lead asset after adverse events

Keros ends mid-stage trial for lead asset after adverse events

Post ContentkrosRead More

You might also be interested in reading Layer-1 Platform Radix Cuts Workforce by 15%.

January 15, 2025
In Mainstream